The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

por Faur, N, Araud, L, Laroche-Clary, A, Kanno, J, Toutain, J, Yamori, T, Robert, J, Le Morvan, V
Publicado 2009

CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells

por Boutin, J., Rosier, J., Cappellen, D., Prat, F., Toutain, J., Pennamen, P., Bouron, J., Rooryck, C., Merlio, J. P., Lamrissi-Garcia, I., Cullot, G., Amintas, S., Guyonnet-Duperat, V., Ged, C., Blouin, J. M., Richard, E., Dabernat, S., Moreau-Gaudry, F., Bedel, A.
Publicado 2021